<- Go Home

United-Guardian, Inc.

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company’s pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Market Cap

$45.5M

Volume

13.2K

Cash and Equivalents

$1.9M

EBITDA

$3.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$6.5M

Profit Margin

53.03%

52 Week High

$16.25

52 Week Low

$7.02

Dividend

N/A

Price / Book Value

3.83

Price / Earnings

14.01

Price / Tangible Book Value

3.83

Enterprise Value

$36.1M

Enterprise Value / EBITDA

9.65

Operating Income

$3.6M

Return on Equity

27.94%

Return on Assets

17.06

Cash and Short Term Investments

$9.4M

Debt

N/A

Equity

$11.9M

Revenue

$12.2M

Unlevered FCF

$2.2M

Sector

Personal Care Products

Category

N/A

Company Stock Pitches